Positional therapy vs continuous positive airway pressure (CPAP)
Cognitive dysfunction · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 13 participantsGRADE not reported
Findings
What do systematic reviews say?
107 questions · 109 findings · 12 reviews
No studies found 23 · 21.1%GRADE not reported 5 · 4.6%Very low 19 · 17.4%Low 38 · 34.9%Moderate 22 · 20.2%High 2 · 1.8%
PAP therapy vs usual care
All‐cause mortality · heart failure associated with central sleep apnoea
It is very uncertain whether PAP therapy changes all‐cause mortality compared with usual care (very low certainty).
1 finding from 1 review
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyRR 0.81 [0.54, 1.21]6 studies · 1804 participantsVery low
PAP therapy vs usual care
Cardiac disease‐ related mortality · heart failure associated with central sleep apnoea
PAP therapy showed no clear difference in cardiac‐related mortality compared with usual care (moderate certainty).
1 finding from 1 review
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyRR 0.97 [0.77, 1.24]5 studies · 1775 participantsModerate
PAP therapy vs usual care
Patient readmissions · heart failure associated with central sleep apnoea
PAP therapy showed no clear difference in all‐cause rehospitalisation compared with usual care (low certainty).
1 finding from 1 review
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyRR 0.95 [0.7, 1.3]5 studies · 1533 participantsLow
PAP therapy vs usual care
Cardiac‐related rehospitalisation · heart failure associated with central sleep apnoea
PAP therapy showed no clear difference in cardiac‐related rehospitalisation compared with usual care (low certainty).
1 finding from 1 review
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyRR 0.97 [0.7, 1.35]5 studies · 1533 participantsLow
PAP therapy vs usual care
QoL · heart failure associated with central sleep apnoea
2 findings from 1 review
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 1617 participantsLow
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 1458 participantsLow
PAP therapy vs usual care
Adverse events · heart failure associated with central sleep apnoea
1 finding from 1 review
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 1412 participantsLow
Positive expiratory pressure plus routine treatment vs routine treatment alone
All‐cause mortality · people with pneumonia
1 finding from 1 review
- no estimate extracted1 study · 98 participantsVery low
Positive expiratory pressure plus routine treatment vs routine treatment alone
Cure rate · people with pneumonia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Positive expiratory pressure plus routine treatment vs routine treatment alone
Length of hospital stay · people with pneumonia
1 finding from 1 review
- no estimate extracted1 study · 98 participantsVery low
Positive expiratory pressure plus routine treatment vs routine treatment alone
Duration of fever · people with pneumonia
1 finding from 1 review
- no estimate extracted1 study · 98 participantsVery low
Positive expiratory pressure plus routine treatment vs routine treatment alone
Duration of ICU stay ‐ not reported · people with pneumonia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Positive expiratory pressure plus routine treatment vs routine treatment alone
Duration of mechanical ventilation ‐ not reported · people with pneumonia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
HFNC vs continuous positive airway pressure (CPAP)
Death (before hospital discharge) or BPD (supplemental oxygen/respiratory support at 36 weeks' postmenstrual age if born < 32 weeks' gestation, or 28 days if born ≥ 32 weeks' gestation) · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in death (before hospital discharge) or BPD(supplemental… compared with continuous positive airway pressure (low certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 1.09 [0.74, 1.6]7 studies · 1830 participantsLow
HFNC vs nasal intermittent positive pressure ventilation
BPD (supplemental oxygen/respiratory support at 36 weeks' postmenstrual age if born < 32 weeks' gestation, or 28 days if born ≥ 32 weeks' gestation) · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in BPD (supplemental oxygen/respiratory support at 36 weeks'… compared with nasal intermittent positive pressure ventilation (low certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 1.19 [0.66, 2.12]3 studies · 271 participantsLow
HFNC vs nasal intermittent positive pressure ventilation
Treatment failure within 72 hours of trial entry · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in treatment failure within 72 hours of trial entry compared with nasal intermittent positive pressure ventilation (moderate certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 1.27 [0.9, 1.79]4 studies · 343 participantsModerate
HFNC vs nasal intermittent positive pressure ventilation
Mechanical ventilation within 72 hours of trial entry · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in mechanical ventilation within 72 hours of trial entry compared with nasal intermittent positive pressure ventilation (moderate certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.91 [0.62, 1.33]4 studies · 343 participantsModerate
HFNC vs nasal intermittent positive pressure ventilation
Pneumothorax · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in pneumothorax (during assigned treatment) compared with nasal intermittent positive pressure ventilation (moderate certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.78 [0.4, 1.53]4 studies · 344 participantsModerate
HFNC vs nasal intermittent positive pressure ventilation
Nasal trauma (during assigned treatment) · preterm infants requiring primary respiratory support
Nasal high flow probably leads to lower nasal trauma (during assigned treatment) compared with nasal intermittent positive pressure ventilation (moderate certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.21 [0.09, 0.47]3 studies · 272 participantsModerate
HFNC vs continuous positive airway pressure (CPAP)
Mortality before hospital discharge · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in death (before hospital discharge) compared with continuous positive airway pressure (low certainty).
1 finding from 1 review
- Nasal high flow therapy for primary respiratory support in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.78 [0.44, 1.39]9 studies · 2009 participantsLow